Author:
Zeng Jing-Xin,Luo Quan,Wen Ju,Tian Xin,Zhou Xin,Li Wei,Tang Ya-Ping,Zhang San-Quan,Liu Wei-Yu,Zhu Hui-Lan,Zhang Xi-Bao
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine,General Medicine
Reference5 articles.
1. Psoriasis;Nestle;N Engl J Med,2009
2. The potential of interleukin-17 to mediate hematopoietic response;Krstic;Immunol Res,2012
3. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial;McInnes;Lancet,2015
4. American Academy of Dermatology annual meeting: Washington, DC, USA, 1-5 March 2019;Fraser;J Am Clin Dermatol,2019
5. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: results from the CLEAR study;Blauvelt;J Am Acad Dermatol,2017
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献